uric acid has been researched along with Edema, Cardiac in 2 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
Edema, Cardiac: Abnormal fluid retention by the body due to impaired cardiac function or heart failure. It is usually characterized by increase in venous and capillary pressure, and swollen legs when standing. It is different from the generalized edema caused by renal dysfunction (NEPHROTIC SYNDROME).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tolvaptan exerts diuretic effects and causes body weight loss at the low dose of 7." | 5.15 | Phase III clinical pharmacology study of tolvaptan. ( Hirayama, A; Hori, M; Inomata, T; Izumi, T; Matsuzaki, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chappell, D | 1 |
| Jacob, M | 1 |
| Hofmann-Kiefer, K | 1 |
| Rehm, M | 1 |
| Welsch, U | 1 |
| Conzen, P | 1 |
| Becker, BF | 1 |
| Inomata, T | 1 |
| Izumi, T | 1 |
| Matsuzaki, M | 1 |
| Hori, M | 1 |
| Hirayama, A | 1 |
1 trial available for uric acid and Edema, Cardiac
| Article | Year |
|---|---|
Phase III clinical pharmacology study of tolvaptan.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Asian People; Benzazepines; Body | 2011 |
1 other study available for uric acid and Edema, Cardiac
| Article | Year |
|---|---|
Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion.
Topics: Animals; Antithrombins; Capillary Permeability; Coronary Vessels; Edema, Cardiac; Endothelial Cells; | 2009 |